Prestige Biopharma Innovative Discovery Center is dedicated to developing novel therapeutic antibodies to tackle unmet medical needs. Leveraging expertise and resources, we focus on first-in-class antibodies, addressing life-threatening diseases and fostering innovation. At IDC, our emphasis is on diverse antibody biologics discovering, starting with Prestige Biopharma’s proprietary oncology targets, PAUF and CTHRC1. IDC’s also plays a vital role in developing next generation vaccines and diagnostics for current and potential pandemics.

Join the Innovative Discovery Center’s Open Innovation Ecosystem, where we aim to evolve into a dynamic ‘Open Innovation Center.’ Through collaborative efforts in science and technology, we strive to advance a future that enhances human life, fostering value growth and achieving scientific milestones through mutual contributions.

Let’s shape our future together. At IDC, we’re leveraging the “fast drop & go” strategy for biosimilars and first-in-class therapeutics. Actively collaborating with universities and research institutions, we’re establishing an open ecosystem to harmonize scientific experiences.